Skip to main content
Antengene Corporation Limited logo

Antengene Corporation Limited — Investor Relations & Filings

Ticker · 6996 ISIN · KYG039571008 LEI · 655600N0NSGOMS4CVH68 HKEX Manufacturing
Open in API
Filings indexed 307 across all filing types
Latest filing 2026-05-20 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 6996

About Antengene Corporation Limited

http://www.antengene.com

Antengene Corporation Limited is a commercial-stage, R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel oncology therapeutics. The company's pipeline includes proprietary programs advancing to pivotal trials and commercialized assets such as selinexor and eltanexor. Antengene aims to deliver advanced anti-cancer drugs to patients across Greater China, the Asia Pacific region, and international markets.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT APPOINTMENT OF CHIEF SCIENTIFIC OFFICER
Board/Management Information Classification · 85% confidence The document is a company announcement of the appointment of a new Chief Scientific Officer, detailing changes in senior management (Board appointment information). It is not a full financial report, earnings release, or regulatory filing of another type, but rather a voluntary management change announcement. This aligns with the Board/Management Information category (MANG).
2026-05-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
Share Issue/Capital Change Classification · 100% confidence The document is a detailed monthly return filed with the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Antengene Corporation Limited. It includes information on authorized and issued share capital, share options, restricted share unit schemes, and confirmations related to public float sufficiency. The document is structured as a regulatory return form (FF301) specific to equity issuers under Chapter 19B of the Exchange Listing Rules. It does not contain financial statements, earnings data, management discussion, or audit information. It primarily reports on share capital movements and share option schemes, which aligns with disclosures about share capital changes and share issuance activities. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA). The document length (over 10,000 characters) and detailed data confirm it is the report itself, not just an announcement or certification.
2026-05-07 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 92% confidence The document is a Form of Proxy for the company’s Annual General Meeting, used to solicit shareholder votes and provide instructions for appointing proxies. This falls under materials sent to shareholders to request votes for a meeting, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-29 English
NOTICE OF THE ANNUAL GENERAL MEETING
AGM Information Classification · 90% confidence The document is the official notice of the Annual General Meeting (AGM) of Antengene Corporation Limited, detailing the date, time, venue, resolutions to be proposed, and voting arrangements. It is clearly an AGM notice rather than the full Annual Report, earnings release, or proxy solicitation materials. Therefore, it fits the “AGM Information” category (Code: AGM-R).
2026-04-29 English
(1) PROPOSALS FOR GENERAL MANDATES TO ISSUE AND RESELL SHARES AND TO REPURCHASE SHARES; (2) RE-ELECTION OF DIRECTORS; (3) RE-APPOINTMENT OF THE AUDITOR; (4) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSO
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a shareholder circular sent in advance of the Annual General Meeting. It contains proposals for general mandates, re-election of directors, re-appointment of auditor, amendments to articles, explanatory statements, and notice of meeting with proxy voting instructions. This format matches a ‘Proxy Solicitation & Information Statement’ (PSI), as it requests shareholder votes rather than presenting financial results or audit opinions.
2026-04-29 English
PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is a regulatory announcement under Hong Kong Listing Rule 13.51(1) notifying shareholders of proposed amendments to the company’s memorandum and articles of association and the adoption of a new amended and restated constitution, which are internal governance instruments. It does not contain full meeting materials or Q&A (excluding CT or PSI), nor financial statements or operational performance. This relates directly to the company’s governance framework and internal rules, matching the Governance Information category.
2026-04-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.